News

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...
Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy according to analysts. On August 14, Eli Lilly and ...
Eli Lilly & Co. raises Mounjaro prices in the United Kingdom to reduce costs in the U.S. Weight-loss drug prices increase by 170% in the U.K., but its National Health Service prices remained unchanged ...
The integration aims to simplify access to Zepbound for eligible members while providing comprehensive, whole-person care to ...
The NHS will prescribe the weight-loss jab Mounjaro to more people in response to a dramatic price increase for private ...
Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight, potentially transforming diabetes and obesity treatment.
Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...
Huge dividends from Denmark’s weight loss drug industry are result of high-tax and high-investment economy, says Nobel Prize winner Morten Meldal.
At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...
Nike co-founder Phil Knight and his wife, Penny Knight, are donating $2 billion to Oregon Health & Science University's Knight Cancer Institute, the largest known single gift to a U.S. university. The ...